Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
3,453
-1,165
-25% -$157K 0.01% 901
2026
Q1
$658K Buy
4,618
+423
+10% +$66.8K 0.01% 677
2025
Q4
$731K Buy
4,195
+1,068
+34% +$198K 0.02% 649
2025
Q3
$635K Sell
3,127
-641
-17% -$131K 0.02% 473
2025
Q2
$649K Buy
3,768
+1,879
+99% +$303K 0.02% 506
2025
Q1
$293K Sell
1,889
-243
-11% -$41.8K 0.02% 433
2024
Q4
$392K Buy
+2,132
New +$404K 0.02% 423

Other funds holding PTC

Callan Family Office's PTC Position: Q2 2026 in Review

Callan Family Office reduced its PTC (PTC) stake by 25% in Q2 2026, selling an estimated $157K and leaving 3,453 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #901.

Callan Family Office first reported a position in PTC in Q4 2024 and has held it in 7 quarters since. The position peaked at $731K in Q4 2025. 685 funds tracked by Wall St. Rank hold PTC as of Q2 2026.

  • Callan Family Office held 3,453 shares of PTC worth $392K as of Q2 2026.
  • Callan Family Office sold 1,165 PTC shares in Q2 2026, an estimated $157K.
  • PTC made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #901 holding.
  • Callan Family Office first reported a position in PTC in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's PTC position peaked at $731K in Q4 2025.
  • 685 funds tracked by Wall St. Rank held PTC as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.